RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high …

A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high …

Add to Collection
RCTs H Zhang, J Gu, A Chao, Q Cheng, D Teng… - Acta pharmacologica …, 2023 - nature.com

Chapter : Section13, Section16, Section18, Section5
Journal Year : 2023
Cited by : 1

… (FREEDOM) study, a subcutaneous injection of 60 mg denosumab every 6 … diabetes or type 2 diabetes beyond the control of drug therapy (patients using treatment drugs such as insulin…..... Read More

Keywords : ['phase iii randomize doubleblind placebocontrolle trial', 'postmenopausal chinese woman', 'denosumab biosimilar', 'osteoporosis', 'high']
PubMed Link : https://www.nature.com/articles/s41401-022-00954-y
Google Scholar Link : https://scholar.google.com/scholar?cites=6324330523501858620&as_sdt=5,33&sciodt=0,33&hl=en&num=20